deferiprone and 3-nitrotyrosine

deferiprone has been researched along with 3-nitrotyrosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ji, L; Li, L; Liu, R; Liu, X; Mu, S; Sui, M; Wang, M; Xie, R; Zou, C	1

Other Studies

1 other study(ies) available for deferiprone and 3-nitrotyrosine

Article	Year
Effect of the oral iron chelator deferiprone in diabetic nephropathy rats. Journal of diabetes, 2017, Volume: 9, Issue:4 Topics: Administration, Oral; Animals; Blotting, Western; Chemokine CCL2; Cyclooxygenase 2; Deferiprone; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Dose-Response Relationship, Drug; Gene Expression; Immunohistochemistry; Iron Chelating Agents; Kidney; Male; Matrix Metalloproteinase 9; Microscopy, Electron, Transmission; NF-kappa B; Protective Agents; Pyridones; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1; Tyrosine	2017

Article

Year

Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.

Journal of diabetes, 2017, Volume: 9, Issue:4

Topics: Administration, Oral; Animals; Blotting, Western; Chemokine CCL2; Cyclooxygenase 2; Deferiprone; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Dose-Response Relationship, Drug; Gene Expression; Immunohistochemistry; Iron Chelating Agents; Kidney; Male; Matrix Metalloproteinase 9; Microscopy, Electron, Transmission; NF-kappa B; Protective Agents; Pyridones; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1; Tyrosine

2017